通过重塑前转移性免疫微环境来调节瘤转移的外体细胞的进展
Jiangning Xiang1, Lin Yao1, Shan Wang1
1Cancer Center, Beijing Friendship Hospital, Capital Medical University, No. 95 Yong an Road, Xi Cheng District, Beijing 100053, China.
Cellular immunology
|May 14, 2025
概括
外体细胞通过改变免疫微环境并促进瘤细胞殖民,促进癌症转移. 了解外体机制对于开发新型免疫疗法和临床应用至关重要.
科学领域:
- 在瘤学瘤学.
- 细胞生物学 细胞生物学
- 免疫学 免疫学 免疫学
背景情况:
- 外体是细胞间通信的关键媒介,在瘤微环境中至关重要.
- 它们携带影响细胞功能和转移部位准备的生物分子.
- 外体促进了原发性和前转移性瘤微环境之间的交叉通话.
研究的目的:
- 阐明外体在转移前免疫微环境中的作用和机制.
- 详细说明外体如何调节免疫细胞功能以促进瘤转移.
- 讨论癌症免疫疗法和临床应用的基于外体的策略.
主要方法:
- 文献综述和对转移中的外体细胞功能当前研究的综合.
- 对外体介导细胞间通信通路的分析.
- 在前转移性利基体内的免疫细胞调节中对外体的作用的探索.
主要成果:
- 外基因组通过修改转移前免疫微环境来促进瘤细胞的殖民化.
- 外体细胞对免疫细胞进行重新编程,创造了一个转移前的环境.
- 基于外体细胞的疗法在临床应用方面仍然存在重大挑战.
结论:
- 外体是前转移性免疫微环境的关键调节者,驱动癌症转移.
- 向外体功能对新型癌症免疫治疗策略有前途.
- 需要进一步的研究,以克服癌症治疗中的外体细胞的临床应用挑战.
相关概念视频
The Tumor Microenvironment
6.5K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.5K
Overview of Exosomes
2.7K
Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
2.7K
Metastasis
5.5K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K
Mesenchymal Stem Cells
4.6K
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
4.6K
Tumor Immunotherapy
411
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
411


